舒洛地特治疗2型糖尿病肾病尿微量白蛋白的疗效观察 |
| |
引用本文: | 任健,苏颉,黄灿,田晨光.舒洛地特治疗2型糖尿病肾病尿微量白蛋白的疗效观察[J].中国航天工业医药,2010(11):31-33. |
| |
作者姓名: | 任健 苏颉 黄灿 田晨光 |
| |
作者单位: | [1]郑州大学第二附属医院内分泌及代谢病科,450014 [2]河南省洛阳市中心医院内分泌科,450014 |
| |
摘 要: | 目的探讨舒洛地特治疗2型糖尿病肾病尿微量白蛋白的疗效。方法 41例糖尿病肾病微量白蛋白尿期患者(200μg/min≤UAER〈200μg/min)被随机分为两组,A组(18例)为常规治疗,B组(23例)为常规+舒洛地特(600LSU,iv,qd)治疗,疗程均为4周。结果治疗4周后,B组UAER降低(41.7±0.4)%明显高于A组(5.1±0.2)%。B组治疗前后以及两组治疗后UAER比较,均有统计学差异(P〈0.001)。而A组治疗前后无统计学差异(P〉0.05)。结论常规治疗基础上加用舒洛地特4周治疗可有效降低2型糖尿病肾病微量白蛋白尿期患者尿微量白蛋白。
|
关 键 词: | 舒洛地特 2型糖尿病 糖尿病肾病 尿微量白蛋白排泄率 |
Effect of sulodexide on microalbuminuria of the third stage of type 2 diabetic nephropathy |
| |
Institution: | Ren Jian,Su Jie,Huang Can,et al.(Department of Endocrinology and Metabolism,The Second Affiliated Hospital of Zhengzhou University,Zhengzhou 450014 ) |
| |
Abstract: | Objective To investigate the effect of sulodexide on the diabetic nephropathy patients with microalbuminuria.Methods 41 patients of type 2 diabetic nephropathy patients with microalbuminuria(200μg/min≤UAER200μg/min)were divided into two group according to the different treatment protocols:the group A,the regular therapy(18 patients) and the group B,the additional sulodexide(600LSU iv qd) based on regular therapy(23 patients).The course of treatment were 4 weeks.Results UAER decreased by(5.1±0.2)% and(41.7±0.4)% in the group A and the group B respectively.Obviously,the latter had a significantly advantage in the decrease of microalbuminuria.Significant difference was noted in the UAER level of the B group compared with its pretherapy and the posttreatment of group A(P〈0.001).But there was no significant difference between the pretherapy and the posttreatment of A group(P〉0.05).Conclusion Four weeks therapy of additional sulodexide based on regular therapy could effectively decreased microalbuminuria in patient with type 2 diabetic nephropathy. |
| |
Keywords: | Sulodexide Type 2 diabetes mellitus(T2DM) Diabetic nephropathy(DN) Urinary albumin excretion rate(UAER) |
本文献已被 维普 等数据库收录! |
|